Home Data Calendar Blog

AMPH

Tables

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 NA 0.00 NA NA NA

Weighted Average Number Of Diluted Shares Outstanding NA 51.86 52.05 53.01 NA 53.92 53.10 51.97 NA 52.79 53.23 51.98 NA 50.01 49.55 49.52 NA 49.85 46.75 48.25 46.84 50.08 49.89 50.42 49.18 48.28 46.56 46.51 49.33 48.22 47.87 48.06 46.10 47.95 45.97 46.81 0.05 45.31 44.85 44.60 44.65 44.64 39.77 38.77 39.14 38.71 38.85 38.84

Weighted Average Number Of Shares Outstanding Basic NA 48.62 48.91 48.21 NA 48.70 48.40 48.00 NA 48.90 48.86 48.14 NA 48.02 47.73 47.52 NA 47.50 46.75 46.41 46.84 47.24 47.11 46.74 46.27 46.24 46.56 46.51 46.23 46.10 46.02 46.07 46.10 45.40 44.96 45.04 0.05 45.31 44.85 44.60 44.65 44.64 39.77 38.77 38.72 38.71 38.71 38.71

Earnings Per Share Basic 0.79 0.83 0.77 0.90 0.75 1.01 0.54 0.54 0.70 0.32 0.35 0.50 0.41 0.62 0.16 0.11 -0.13 0.08 0.00 0.09 -0.02 0.03 1.01 0.02 0.04 0.05 -0.06 -0.16 0.03 0.00 0.04 0.02 -0.06 0.09 0.15 0.06 0.17 -0.07 -0.15 -0.01 -0.06 -0.12 -0.03 -0.04 0.05 0.00 0.20 0.06

Earnings Per Share Diluted 0.74 0.78 0.73 0.81 0.69 0.91 0.49 0.50 0.65 0.30 0.33 0.47 0.40 0.59 0.16 0.10 -0.13 0.08 0.00 0.08 -0.02 0.03 0.96 0.02 0.04 0.05 -0.06 -0.16 0.03 0.00 0.04 0.02 -0.06 0.08 0.15 0.05 0.16 -0.07 -0.15 -0.01 -0.06 -0.12 -0.03 -0.04 0.05 0.00 0.20 0.06

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Revenues 186.52 191.21 182.39 171.84 178.10 180.56 145.71 140.02 135.02 120.13 123.47 120.37 120.89 112.20 101.66 103.02 95.92 83.43 85.81 84.69 83.38 80.14 79.05 79.79 89.69 75.54 71.04 58.39 60.40 57.92 65.19 56.67 63.54 64.22 68.03 59.37 76.91 63.87 53.85 56.89 55.88 59.71 49.00 45.87 54.88 59.32 62.52 52.96

Cost Of Revenue 99.88 89.27 87.23 81.74 81.97 72.15 72.97 66.18 63.85 61.62 60.11 64.54 64.65 61.02 54.29 58.07 59.09 46.92 52.63 47.87 50.00 44.88 46.66 48.89 55.00 46.28 44.88 41.33 39.82 37.27 38.44 33.84 43.58 36.61 36.32 34.46 43.74 46.29 40.53 43.61 43.92 47.92 34.01 33.36 35.25 39.04 35.03 NA

Gross Profit 86.65 101.94 95.17 90.10 96.14 108.40 72.74 73.84 71.17 58.51 63.36 55.83 56.23 51.18 47.38 44.95 36.83 36.51 33.18 36.82 33.38 35.25 32.39 30.90 34.69 29.26 26.16 17.06 20.58 20.64 26.75 22.83 19.96 27.61 31.71 24.90 33.17 17.58 13.32 13.28 11.96 11.79 15.00 12.51 19.63 20.28 27.49 19.56

Operating Expenses 41.50 44.89 39.95 42.09 42.16 35.73 35.84 40.41 33.34 35.28 38.53 34.21 31.98 26.41 36.82 34.64 33.95 32.99 36.10 29.34 33.62 32.85 31.41 34.08 33.14 26.71 29.01 26.98 22.24 23.46 24.56 21.42 24.47 21.82 21.38 20.83 18.80 21.33 23.58 20.54 18.98 19.61 16.17 14.48 16.70 20.05 15.51 NA

Research And Development Expense 18.14 21.08 17.65 17.04 20.42 16.66 16.84 19.82 17.24 18.51 22.80 16.22 17.29 10.76 18.12 14.77 18.13 17.64 16.15 15.30 19.64 18.61 16.00 14.61 16.73 11.34 15.47 14.26 11.39 10.04 10.73 11.25 12.61 9.72 10.48 8.39 8.65 11.12 10.73 6.57 7.64 8.59 5.99 6.21 7.28 9.04 7.79 NA

General And Administrative Expense 12.94 14.82 13.29 15.68 13.12 12.65 12.28 13.48 10.63 11.98 9.98 12.47 10.62 10.91 14.56 15.34 12.03 11.67 15.92 10.75 10.51 11.02 12.43 16.33 13.81 13.41 11.67 11.00 9.22 11.66 12.23 11.34 10.70 10.80 9.46 10.87 8.71 9.03 11.31 12.45 9.77 9.56 8.64 6.84 8.01 9.54 6.51 NA

Selling And Marketing Expense 10.42 8.99 9.01 9.37 8.62 6.41 6.72 7.11 5.47 4.78 5.76 5.52 4.08 4.75 4.13 4.54 3.79 3.67 4.03 3.29 3.48 3.22 2.99 3.14 2.60 1.96 1.88 1.72 1.63 1.76 1.60 1.48 1.49 1.29 1.33 1.35 1.31 1.17 1.47 1.52 1.50 1.45 1.35 1.26 1.29 1.46 1.20 NA

Operating Income Loss 45.14 57.05 55.22 48.01 53.98 72.68 36.90 33.43 37.83 23.23 24.82 21.61 24.25 24.77 10.56 10.31 2.88 3.52 -2.92 7.48 -0.24 2.40 0.97 -3.17 1.54 2.55 -2.86 -9.92 -1.66 -2.82 2.19 1.40 -4.51 5.80 10.33 4.08 14.37 -3.75 -10.26 -7.26 -7.02 -7.82 -1.17 -1.97 2.93 0.23 11.98 NA

Interest Paid Net 4.42 8.53 5.23 8.63 5.47 9.33 1.53 1.25 1.06 0.79 0.59 0.58 0.24 0.87 0.49 0.51 0.52 0.56 0.56 0.56 0.56 0.60 0.38 0.90 0.65 0.65 0.55 0.53 0.54 0.54 0.40 0.39 0.34 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Allocated Share Based Compensation Expense 5.63 5.60 5.78 7.36 4.62 4.64 4.87 6.11 4.30 4.30 4.24 5.02 3.85 3.92 6.08 4.83 4.33 4.37 6.51 5.28 4.29 4.29 4.03 4.67 3.91 3.91 4.20 4.67 4.18 4.16 4.30 4.45 3.52 3.56 4.20 3.85 3.46 3.43 3.70 2.23 2.60 2.66 2.40 1.62 NA NA NA NA

Income Tax Expense Benefit 6.00 7.25 12.29 4.13 4.67 14.03 6.38 6.75 7.29 6.56 5.55 4.08 7.19 6.69 5.59 1.16 -0.95 2.29 -0.07 2.28 0.43 0.60 14.17 -1.48 -1.13 0.96 -1.33 -1.78 -2.53 -2.17 1.20 0.61 -1.88 2.11 2.86 1.33 2.81 -1.27 -3.58 -5.53 -3.30 -2.60 -0.70 -0.85 0.95 0.49 4.11 NA

Income Taxes Paid 11.10 12.07 16.58 0.35 46.87 0.81 0.99 0.34 9.28 11.20 23.78 0.18 2.62 0.90 4.55 0.03 0.60 2.15 0.45 0.21 1.53 3.04 0.91 0.23 0.18 0.01 0.14 0.01 0.00 0.31 4.13 0.44 0.13 2.71 0.19 0.37 0.10 NA NA NA 0.35 0.00 NA NA 0.14 3.94 NA NA

Profit Loss 37.96 40.43 37.95 43.18 36.17 49.22 26.12 26.03 33.91 15.87 17.35 24.25 19.76 30.96 8.62 3.96 -5.79 4.79 -1.43 3.52 0.76 0.98 46.92 -2.15 1.87 1.62 -2.85 -7.14 0.79 0.10 1.90 0.86 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss 37.96 40.43 37.95 43.18 36.17 49.22 26.12 26.03 33.91 15.87 17.35 24.25 19.76 29.55 7.77 5.04 -6.27 3.92 -0.19 3.95 -1.03 1.31 47.79 0.87 1.87 2.39 -2.79 -7.25 1.47 0.17 1.97 0.89 -2.74 3.89 6.89 2.49 7.53 -3.01 -6.65 -0.67 -2.52 -5.38 -1.18 -1.62 1.83 -0.16 7.81 2.38

Comprehensive Income Net Of Tax 37.60 40.43 37.89 42.89 36.10 49.13 26.07 26.39 35.22 14.65 15.88 23.77 19.27 28.20 8.48 3.12 -5.52 4.61 0.10 3.17 0.14 -0.32 47.69 0.76 1.43 1.98 -5.05 -6.06 1.96 0.80 2.98 1.36 -4.86 4.00 6.24 2.92 8.82 -2.63 -6.13 -3.66 -2.37 -6.91 -1.45 NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Assets 1577.47 1545.18 1491.52 1574.32 1512.91 1544.63 1378.27 773.66 741.99 726.70 723.72 716.24 671.53 651.68 665.75 645.74 631.24 613.72 600.06 572.83 586.97 585.64 601.30 544.72 513.56 480.64 451.65 449.78 454.67 437.77 444.00 435.61 427.74 428.84 408.59 395.01 390.14 395.03 398.93 396.50 389.37 401.13 397.27 NA 338.75 NA NA NA

Liabilities 845.17 817.50 778.18 901.96 873.49 949.49 789.03 225.08 213.33 221.53 224.41 236.71 226.01 221.50 198.52 194.78 182.51 162.76 157.62 149.46 159.44 151.98 169.01 164.45 149.20 139.37 131.12 122.68 117.34 107.11 110.68 110.05 98.48 100.38 101.12 98.42 94.63 111.24 113.66 117.22 107.51 118.01 109.53 NA 87.20 NA NA NA

Liabilities And Stockholders Equity 1577.47 1545.18 1491.52 1574.32 1512.91 1544.63 1378.27 773.66 741.99 726.70 723.72 716.24 671.53 651.68 665.75 645.74 631.24 613.72 600.06 572.83 586.97 585.64 601.30 544.72 513.56 480.64 451.65 449.78 454.67 437.77 444.00 435.61 427.74 428.84 408.59 395.01 390.14 395.03 398.93 396.50 389.37 401.13 397.27 NA 338.75 NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Assets Current 534.07 545.95 482.64 555.08 489.60 543.00 384.55 407.67 378.32 384.22 377.14 364.42 318.12 303.67 310.97 300.16 279.68 276.54 266.82 246.72 255.24 268.90 284.13 230.14 220.34 194.80 169.95 174.05 187.78 176.49 193.58 191.42 184.10 190.19 181.31 173.44 175.93 199.06 203.90 202.60 198.00 215.18 214.23 NA 172.97 NA NA NA

Cash And Cash Equivalents At Carrying Value 151.61 192.12 189.62 201.15 144.30 266.78 148.59 176.62 156.10 157.24 166.16 172.63 126.35 106.61 105.43 101.60 92.64 87.91 87.39 54.84 73.69 85.61 120.37 79.10 86.34 68.73 48.07 54.55 65.59 66.92 82.54 76.77 72.35 66.60 66.66 63.33 66.07 70.68 74.46 68.59 67.83 72.88 64.08 52.13 53.59 51.94 55.95 NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 151.84 192.35 189.85 201.38 144.53 271.04 151.28 176.85 156.33 157.48 166.39 172.86 126.59 106.84 124.59 101.84 94.51 89.78 89.25 56.71 75.55 87.48 122.24 80.96 88.20 70.60 49.94 56.41 67.46 68.78 84.41 76.89 72.35 NA NA NA 66.07 NA NA NA NA NA NA NA NA NA NA NA

Short Term Investments 70.04 58.38 28.16 88.41 112.51 33.10 14.54 16.28 19.66 26.84 17.23 14.38 10.32 8.02 11.74 13.53 12.98 10.87 11.10 12.20 11.68 12.67 2.84 2.83 2.83 2.83 2.82 2.83 2.63 2.52 0.73 0.75 0.53 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accounts Receivable Net Current 136.29 139.63 131.41 138.11 114.94 118.99 104.72 100.64 88.80 77.10 80.81 73.17 78.80 78.09 67.89 77.94 66.00 52.38 49.86 57.78 45.38 45.26 48.82 54.93 52.16 43.82 41.28 31.88 36.00 24.15 24.12 25.89 26.78 26.55 23.13 23.08 33.23 25.00 19.83 21.65 22.85 26.60 18.60 NA 24.59 NA NA NA

Inventory Net 153.74 130.32 122.41 115.49 105.83 109.98 104.62 103.65 103.58 103.25 98.73 95.15 92.81 100.24 97.93 97.11 96.83 108.87 104.73 107.90 110.50 109.85 99.23 78.58 69.32 65.41 61.68 62.78 63.61 69.64 74.46 78.14 79.75 90.65 88.33 82.24 70.67 72.42 80.17 84.89 82.33 88.05 106.02 NA 69.92 NA NA NA

Inventory Finished Goods 39.42 33.76 27.41 30.75 24.93 26.50 28.22 24.86 18.89 17.61 14.75 14.53 17.66 16.93 18.68 18.77 12.52 18.04 14.90 13.72 15.72 15.60 17.38 14.75 8.90 10.55 11.74 18.71 21.17 22.85 23.03 20.66 21.28 29.35 30.74 26.40 19.87 19.35 22.11 20.64 24.75 23.43 34.18 NA 26.50 NA NA NA

Inventory Raw Materials And Supplies 81.51 60.54 56.44 51.41 50.08 55.18 44.63 47.92 47.61 47.08 43.90 40.36 41.85 45.75 43.75 43.26 47.05 52.40 50.66 54.50 59.23 57.04 45.63 32.65 30.15 28.56 27.64 22.27 19.97 22.01 24.91 33.49 36.21 47.24 42.57 38.13 31.88 32.55 36.02 45.59 42.00 42.05 51.16 NA 34.47 NA NA NA

Prepaid Expense And Other Assets Current 18.21 17.72 7.95 8.70 9.06 6.20 5.87 7.33 7.56 5.99 5.90 6.43 7.27 7.75 5.89 6.75 6.78 10.99 9.00 9.02 9.54 10.47 8.49 8.96 5.49 6.67 4.40 5.66 9.75 8.66 7.19 8.15 3.27 3.98 1.75 3.09 4.44 4.20 3.26 3.93 3.68 4.91 3.70 NA 5.03 NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Property Plant And Equipment Gross 568.93 561.57 546.18 540.13 528.04 518.59 510.88 470.06 458.30 445.94 445.60 446.50 443.86 437.48 447.75 442.51 444.20 424.71 411.69 400.10 398.26 382.21 376.32 367.08 359.51 350.54 337.95 328.51 318.67 303.43 289.19 281.72 274.96 271.40 265.35 259.68 254.42 250.92 246.98 243.48 240.84 233.44 230.15 NA 207.19 NA NA NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 271.59 266.19 258.18 251.61 245.30 237.75 232.35 226.58 220.03 213.19 208.03 203.25 199.62 194.55 195.16 189.24 184.15 178.83 173.45 168.62 164.41 160.06 156.26 152.24 149.09 148.01 139.71 136.60 133.33 130.38 127.47 124.33 122.01 119.45 116.71 114.99 112.26 109.74 107.73 105.20 102.55 99.33 96.16 NA 90.58 NA NA NA

Amortization Of Intangible Assets 6.18 6.18 6.19 6.17 6.18 6.18 0.23 0.24 0.33 0.39 0.34 0.35 0.36 0.38 0.28 0.28 0.27 0.26 0.25 0.26 0.26 0.25 0.17 0.36 0.27 0.27 0.72 0.73 0.72 0.71 0.70 0.72 0.77 0.70 0.57 0.48 0.48 0.48 0.50 0.48 0.48 0.48 0.48 0.47 0.48 0.48 NA NA

Property Plant And Equipment Net 297.35 295.38 288.00 288.52 282.75 280.84 278.53 243.48 238.27 232.74 237.56 243.25 244.24 242.92 252.59 253.26 260.06 245.88 238.24 231.48 233.86 222.16 220.06 214.84 210.42 202.53 198.24 191.91 185.34 173.05 161.72 157.39 152.94 151.95 148.65 144.68 142.16 141.18 139.25 138.28 138.29 134.11 133.99 NA 116.62 NA NA NA

Long Term Investments 11.00 NA 9.94 15.16 14.69 0.97 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Goodwill 3.05 3.26 3.13 3.15 3.22 3.09 3.17 3.17 3.13 2.89 3.05 3.26 3.31 3.39 3.84 3.79 3.94 3.77 3.63 3.57 3.63 3.79 3.93 3.90 3.95 4.00 4.36 4.58 4.46 4.40 4.27 4.03 3.98 4.21 4.16 4.32 3.73 3.83 3.79 3.71 4.47 4.65 0.28 NA 0.28 NA NA NA

Finite Lived Intangible Assets Net 558.39 562.32 568.50 574.69 580.85 587.03 593.21 4.78 4.95 4.93 5.42 5.96 6.33 6.58 6.98 7.22 7.45 7.38 7.41 7.68 8.29 8.13 8.56 9.13 9.09 9.51 9.86 11.04 11.45 12.11 12.37 12.74 17.11 18.30 9.91 10.48 6.95 7.43 7.90 8.39 8.78 9.24 9.71 NA 10.66 NA NA NA

Intangible Assets Net Including Goodwill 590.66 594.80 600.85 607.06 613.29 619.35 625.60 37.18 37.30 37.04 37.70 38.44 38.87 39.19 40.05 40.24 40.62 40.38 40.27 40.47 41.15 41.14 41.72 42.26 42.27 42.73 43.45 44.85 45.14 45.73 45.87 45.99 50.31 51.73 43.30 44.02 39.90 40.48 40.91 41.33 42.56 43.22 39.33 NA 40.16 NA NA NA

Other Assets Noncurrent 25.99 23.66 24.26 23.37 25.91 25.30 20.27 18.54 20.86 20.55 18.68 16.30 16.66 11.61 9.44 7.21 5.25 7.74 12.63 11.19 11.16 12.33 13.52 12.29 9.92 11.13 11.75 10.71 8.66 10.62 10.96 8.94 9.39 7.54 7.88 5.41 4.70 4.36 4.96 4.45 3.59 2.50 3.60 NA 2.88 NA NA NA

Held To Maturity Securities Accumulated Unrecognized Holding Loss 0.03 0.00 0.12 0.12 0.02 0.02 0.01 0.03 0.06 0.08 0.05 0.04 0.01 0.00 NA 0.00 0.00 NA NA NA 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Held To Maturity Securities Fair Value 53.98 31.97 31.59 84.55 89.56 33.63 14.43 19.95 23.45 23.09 12.98 9.68 6.98 3.04 2.43 4.20 1.31 1.76 2.01 NA 2.79 3.79 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Held To Maturity Securities 53.97 31.90 31.70 84.66 89.52 33.66 14.44 19.98 23.52 23.17 13.03 9.72 6.99 3.04 2.43 4.20 1.31 1.76 2.00 NA 2.79 3.79 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Held To Maturity Securities Accumulated Unrecognized Holding Gain 0.03 0.07 NA 0.01 0.06 NA NA NA NA NA NA NA NA NA NA NA NA 0.00 0.01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Held To Maturity Securities Accumulated Unrecognized Holding Loss 0.03 0.00 0.12 0.12 0.02 0.02 0.01 0.03 0.06 0.08 0.05 0.04 0.01 0.00 NA 0.00 0.00 NA NA NA 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Liabilities Current 173.76 159.01 136.97 255.17 225.41 257.96 251.28 105.64 94.86 102.19 103.63 114.36 103.81 97.99 124.55 127.10 112.20 96.72 93.29 83.37 90.01 86.60 101.00 111.96 106.83 96.62 87.59 72.54 67.19 57.40 63.70 72.86 60.62 60.84 65.67 64.92 59.95 70.65 69.40 72.09 62.59 63.08 56.28 NA 65.40 NA NA NA

Accounts Payable Current 30.51 34.09 31.77 36.53 25.44 31.97 18.83 21.98 20.50 19.96 31.07 23.84 22.21 21.66 27.75 22.99 24.36 23.17 21.71 16.51 25.06 22.04 31.46 34.27 31.32 22.67 21.66 15.63 16.63 9.59 14.91 19.30 16.20 13.44 18.77 18.62 13.87 12.27 18.45 18.95 10.16 10.01 17.76 NA 20.38 NA NA NA

Accounts Payable And Accrued Liabilities Current 157.06 153.27 131.21 116.70 93.37 222.72 217.54 88.89 84.24 95.80 97.67 95.81 89.55 88.91 109.60 108.55 95.50 79.29 75.39 65.44 77.05 75.14 88.17 90.80 87.42 76.36 67.09 58.50 57.55 NA NA NA 47.55 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Accrued Liabilities Current 31.57 15.73 10.81 9.43 12.84 10.33 10.24 8.71 9.14 12.69 7.59 9.21 8.79 10.08 11.95 9.60 12.33 8.78 7.65 7.29 10.01 12.11 14.85 10.74 10.75 10.64 6.95 7.04 5.13 NA NA NA 5.03 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accrued Income Taxes Current 9.66 1.28 1.51 5.86 1.61 31.09 17.70 11.59 4.57 1.53 0.60 13.12 9.08 3.96 3.63 2.68 1.08 1.62 2.35 2.99 2.04 1.40 3.15 1.02 1.19 1.67 1.61 7.98 3.33 4.18 6.22 8.10 7.71 6.21 6.65 4.26 3.08 2.09 2.75 3.00 3.12 2.79 2.77 NA 2.85 NA NA NA

Accrued Liabilities Current 126.54 119.18 99.44 80.16 67.93 190.75 198.70 66.91 63.74 75.83 66.59 71.97 67.33 67.25 81.85 85.56 71.15 56.12 53.68 48.93 51.99 53.09 56.71 56.52 56.09 53.69 45.43 42.87 40.93 16.42 17.63 22.60 15.70 14.70 11.17 13.52 16.73 22.62 14.92 14.66 13.14 10.45 10.49 NA 7.63 NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Long Term Debt Noncurrent 613.53 NA NA NA 603.17 653.27 NA NA 76.64 NA NA NA 78.19 NA NA NA 45.92 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Long Term Debt And Capital Lease Obligations 601.63 596.45 586.85 594.01 589.58 638.21 488.28 72.87 72.84 74.01 73.87 74.35 74.78 75.55 30.46 32.33 34.19 32.90 34.62 36.41 39.39 38.08 39.79 30.97 31.98 32.61 33.70 39.71 40.84 42.23 40.11 31.15 32.36 34.16 31.74 29.09 30.16 31.35 34.80 35.89 36.11 41.27 42.85 NA 10.07 NA NA NA

Other Liabilities Noncurrent 20.95 27.04 18.80 17.98 22.72 15.70 17.63 15.18 14.56 14.19 15.33 15.49 15.65 14.88 13.48 13.42 13.21 11.35 11.00 10.26 9.43 8.98 9.03 8.86 8.94 7.96 7.63 8.13 7.06 1.97 1.87 1.77 1.77 1.97 2.02 2.13 1.91 NA NA NA NA NA NA NA NA NA NA NA

Operating Lease Liability Noncurrent 41.88 28.94 29.48 28.74 29.72 30.20 24.41 23.99 23.69 24.37 24.68 25.49 24.70 25.47 24.55 16.46 17.46 17.53 14.53 15.23 16.32 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Stockholders Equity Including Portion Attributable To Noncontrolling Interest 732.30 727.68 713.35 672.36 639.42 595.14 589.24 548.58 528.66 505.17 499.31 479.52 445.52 430.18 467.22 450.96 448.72 450.96 442.44 423.37 427.53 433.65 432.29 380.27 364.36 341.27 316.98 323.62 333.74 327.74 330.48 NA 326.52 NA NA NA 293.49 NA NA NA NA NA NA NA NA NA NA NA

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 NA 0.00 NA NA NA

Additional Paid In Capital 505.40 496.43 487.57 476.07 486.06 477.88 471.11 456.62 455.08 448.74 443.04 433.45 422.42 412.92 427.30 413.93 410.06 404.08 396.84 371.14 367.31 361.70 355.44 349.20 344.43 330.26 322.36 316.67 313.89 303.21 299.11 285.36 283.12 276.54 258.79 250.68 247.83 240.75 236.66 223.31 220.75 219.29 217.00 NA 177.73 NA NA NA

Retained Earnings Accumulated Deficit 568.79 530.82 490.39 452.44 409.27 373.10 323.88 297.75 271.72 237.81 221.94 204.59 180.34 160.58 130.58 122.81 117.77 124.05 120.13 120.32 116.37 117.40 116.09 68.30 67.48 65.62 66.78 69.57 76.23 74.77 74.59 72.62 70.86 73.60 69.71 62.81 60.32 52.79 55.80 62.45 63.11 65.63 71.01 NA 73.81 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -9.18 -8.82 -8.83 -8.77 -8.48 -8.41 -8.32 -8.27 -8.62 -9.93 -8.71 -7.25 -6.76 -6.28 -4.93 -5.64 -3.72 -4.48 -5.17 -5.46 -4.69 -5.85 -4.22 -4.13 -4.01 -3.58 -3.17 -0.91 -2.10 -2.60 -3.22 -4.23 -4.70 -2.58 -2.69 -2.04 -2.48 -3.76 -4.13 -4.65 -1.65 NA NA NA NA NA NA NA

Treasury Stock Value 332.71 290.76 255.80 247.40 247.43 247.44 197.44 197.54 189.52 171.46 156.97 151.28 150.48 137.05 130.96 125.55 121.81 118.42 114.12 108.49 97.63 83.85 79.46 78.39 75.48 72.90 65.45 58.23 50.70 44.73 37.17 28.19 20.03 19.11 18.34 14.88 10.17 5.99 3.06 1.83 0.34 NA NA NA NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA 5.60 5.78 7.36 NA 4.64 4.87 6.11 NA 4.30 4.24 5.02 NA 3.92 5.24 4.83 NA 4.37 6.51 5.28 4.29 4.29 4.03 4.67 3.91 3.91 4.20 4.67 4.18 4.16 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Net Cash Provided By Used In Operating Activities 29.02 59.96 69.11 55.29 23.86 64.33 54.92 40.38 15.23 20.38 2.81 50.77 40.44 2.57 32.16 22.82 16.89 8.81 30.09 1.48 5.65 -12.00 51.72 -3.61 9.52 15.78 4.53 8.36 9.77 2.47 4.57 22.40 14.01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Cash Provided By Used In Investing Activities -35.68 -34.59 -69.90 15.24 -103.05 -31.15 -508.58 -6.33 -0.23 -15.26 -8.18 -9.11 -11.95 -3.77 -4.25 -8.70 -12.18 -5.45 -10.07 -8.72 -7.35 -18.62 -9.67 -14.88 -8.80 -12.88 -11.77 -8.74 -10.13 -14.84 -7.83 -5.96 -7.11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Cash Provided By Used In Financing Activities -33.84 -22.82 -10.72 -13.58 -47.08 86.61 428.11 -13.55 -16.16 -13.93 -0.99 4.65 -8.70 -16.49 -5.19 -6.64 -0.23 -3.03 12.46 -11.45 -10.38 -3.89 -0.74 11.23 16.92 17.80 1.11 -10.83 -0.80 -5.51 10.31 -11.72 -1.26 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Net Cash Provided By Used In Operating Activities 29.02 59.96 69.11 55.29 23.86 64.33 54.92 40.38 15.23 20.38 2.81 50.77 40.44 2.57 32.16 22.82 16.89 8.81 30.09 1.48 5.65 -12.00 51.72 -3.61 9.52 15.78 4.53 8.36 9.77 2.47 4.57 22.40 14.01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss 37.96 40.43 37.95 43.18 36.17 49.22 26.12 26.03 33.91 15.87 17.35 24.25 19.76 29.55 7.77 5.04 -6.27 3.92 -0.19 3.95 -1.03 1.31 47.79 0.87 1.87 2.39 -2.79 -7.25 1.47 0.17 1.97 0.89 -2.74 3.89 6.89 2.49 7.53 -3.01 -6.65 -0.67 -2.52 -5.38 -1.18 -1.62 1.83 -0.16 7.81 2.38

Profit Loss 37.96 40.43 37.95 43.18 36.17 49.22 26.12 26.03 33.91 15.87 17.35 24.25 19.76 30.96 8.62 3.96 -5.79 4.79 -1.43 3.52 0.76 0.98 46.92 -2.15 1.87 1.62 -2.85 -7.14 0.79 0.10 1.90 0.86 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Depreciation Depletion And Amortization NA 9.79 9.68 9.66 9.66 9.62 3.06 3.40 3.44 3.42 3.00 2.74 2.60 2.50 2.64 2.48 2.50 2.46 2.03 2.05 2.07 1.70 1.66 1.64 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Increase Decrease In Accounts Receivable -2.91 8.05 -6.68 23.20 -4.09 19.64 -1.26 11.80 11.55 -3.60 7.78 -5.60 0.76 12.18 -10.09 12.08 13.45 2.25 -8.03 12.49 0.02 -5.02 -2.76 1.06 8.44 2.63 9.86 -4.63 11.01 -0.09 -1.90 -0.92 0.38 3.41 0.03 -10.20 8.31 5.16 -1.83 -0.62 -3.23 8.01 -0.52 -5.47 -6.39 -1.10 NA NA

Increase Decrease In Inventories 24.47 7.31 7.03 9.99 -4.81 5.77 1.03 -0.27 -1.18 5.50 4.74 2.69 -7.03 4.11 0.52 1.14 -12.95 3.41 -3.52 -2.24 -0.04 11.13 20.50 9.51 4.10 3.51 -0.18 -1.44 -6.27 -5.42 -5.07 -1.89 -9.76 2.12 6.58 10.77 -1.23 -7.99 -5.05 4.49 -4.96 -16.40 5.66 9.13 9.84 5.44 NA NA

Share Based Compensation 5.63 5.60 5.78 7.36 4.62 4.64 4.87 6.11 4.30 4.30 4.24 5.02 3.85 3.92 6.08 4.83 4.33 4.37 6.51 5.28 4.29 4.29 4.03 4.67 3.91 3.91 4.20 4.67 4.18 4.16 4.30 4.45 4.64 3.25 3.84 3.40 3.00 2.93 3.53 2.22 2.38 2.41 2.17 1.38 1.52 2.22 NA NA

Amortization Of Financing Costs 0.72 0.74 NA NA 2.91 5.24 NA NA 0.03 0.24 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Net Cash Provided By Used In Investing Activities -35.68 -34.59 -69.90 15.24 -103.05 -31.15 -508.58 -6.33 -0.23 -15.26 -8.18 -9.11 -11.95 -3.77 -4.25 -8.70 -12.18 -5.45 -10.07 -8.72 -7.35 -18.62 -9.67 -14.88 -8.80 -12.88 -11.77 -8.74 -10.13 -14.84 -7.83 -5.96 -7.11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Payments To Acquire Property Plant And Equipment 12.41 13.79 6.04 8.79 9.44 10.19 9.05 9.48 6.31 5.62 5.96 6.14 6.88 7.22 5.74 7.62 9.33 5.63 10.89 8.01 8.41 8.68 9.72 14.74 9.58 12.63 12.25 12.34 10.12 11.41 6.30 7.27 6.92 6.00 4.93 3.53 3.73 3.94 2.96 3.78 7.55 4.03 3.06 4.03 3.75 4.35 NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Net Cash Provided By Used In Financing Activities -33.84 -22.82 -10.72 -13.58 -47.08 86.61 428.11 -13.55 -16.16 -13.93 -0.99 4.65 -8.70 -16.49 -5.19 -6.64 -0.23 -3.03 12.46 -11.45 -10.38 -3.89 -0.74 11.23 16.92 17.80 1.11 -10.83 -0.80 -5.51 10.31 -11.72 -1.26 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Payments For Repurchase Of Common Stock 42.00 34.96 NA NA 0.00 50.00 0.13 8.02 18.07 14.49 6.12 1.23 13.44 6.09 5.56 3.78 3.39 4.33 5.76 10.95 13.78 4.43 1.07 3.02 2.61 7.59 7.23 7.62 5.97 7.59 8.98 8.20 0.92 0.80 3.47 4.72 4.18 2.97 1.23 1.49 -0.10 NA NA NA 0.18 NA NA NA

2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31

Revenues 186.52 191.21 182.39 171.84 178.10 180.56 145.71 140.02 135.02 120.13 123.47 120.37 120.89 112.20 101.66 103.02 95.92 83.43 85.81 84.69 83.38 80.14 79.05 79.79 89.69 75.54 71.04 58.39 60.40 57.92 65.19 56.67 63.54 64.22 68.03 59.37 76.91 63.87 53.85 56.89 55.88 59.71 49.00 45.87 54.88 59.32 62.52 52.96

Anp, Research And Development Services 2.20 0.10 1.50 0.40 2.40 0.80 1.20 0.10 2.20 0.80 0.70 0.60 1.20 2.60 1.00 0.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Anp, Nanjing Hanxin Pharmaceutical Technology Co Ltd 0.00 0.10 0.10 0.30 0.10 0.00 0.00 0.00 0.10 0.30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product 186.98 188.82 179.39 157.63 155.65 151.85 145.71 140.02 135.02 120.13 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Product And Service Other -0.46 2.40 3.01 14.21 22.46 28.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Active Pharmaceutical Ingredient NA 1.46 3.54 1.69 3.07 4.19 2.85 4.01 2.31 3.01 3.34 3.82 2.91 3.21 6.94 5.14 8.12 2.10 4.87 3.39 5.39 4.41 5.31 5.25 6.76 3.78 7.80 5.28 4.42 3.46 1.42 0.74 4.69 5.17 4.28 0.81 10.82 5.97 3.78 6.01 5.90 5.98 0.10 NA NA NA NA NA

Finished Pharmaceutical Products NA 189.75 178.86 170.14 175.03 176.37 142.87 136.01 132.72 117.12 120.12 116.55 117.98 108.99 94.72 97.88 87.80 81.33 80.94 81.30 78.00 75.73 73.73 74.54 82.93 71.77 63.24 53.12 55.98 54.45 63.77 55.93 58.85 59.06 63.76 58.55 66.09 57.90 50.08 50.87 49.98 53.73 48.90 45.87 54.88 59.32 62.52 52.96

Finished Pharmaceutical Products, Baqsimi NA 26.05 30.85 13.84 22.46 28.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Baqsimi Neb NA 2.40 3.01 14.21 NA 28.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Enoxaparin NA 5.62 5.27 7.10 6.09 7.70 7.87 9.87 7.81 7.98 9.03 10.12 7.94 8.03 9.33 10.66 17.65 11.65 10.22 9.17 8.80 9.57 9.84 14.48 19.09 18.56 8.71 7.01 11.35 6.55 8.29 10.41 8.27 15.36 17.33 18.36 19.86 21.26 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Epinephrine NA 26.79 27.94 26.11 24.65 20.20 16.71 20.09 21.43 19.50 18.12 15.16 18.87 13.89 9.19 15.58 7.48 5.37 6.96 3.99 4.31 3.76 3.14 2.68 1.26 1.88 3.69 3.22 3.67 2.03 10.65 9.57 10.74 5.30 5.23 4.39 4.98 5.03 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Finished Pharmaceutical Products Net Revenues NA 187.36 175.85 155.94 152.57 147.66 142.87 NA 132.72 117.12 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Glucagon NA 40.41 27.37 28.54 31.20 29.51 27.28 25.70 16.07 12.62 16.04 10.98 15.34 12.19 12.13 7.98 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Lidocaine NA 15.88 12.80 12.77 14.99 15.52 14.01 13.65 14.71 13.98 13.38 10.59 12.10 11.65 11.59 9.07 12.19 10.66 7.61 10.66 12.28 11.67 10.08 11.98 13.66 9.88 10.01 9.78 10.38 9.60 9.33 8.29 10.22 8.28 8.19 9.91 9.60 6.18 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Naloxone NA 4.04 3.80 4.29 4.23 4.71 5.10 4.96 4.84 6.82 7.19 7.41 6.55 8.03 6.62 6.34 7.08 8.74 8.72 8.88 8.95 10.61 7.83 7.36 7.70 9.43 11.13 8.93 8.43 12.71 10.26 10.94 9.31 12.41 15.56 10.25 10.66 10.52 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Other Finished Pharmaceutical Products NA 35.50 34.65 29.15 35.02 37.73 37.52 30.56 33.08 23.64 25.59 27.11 21.78 27.05 18.75 20.30 19.55 21.46 24.27 24.70 16.28 17.67 21.19 17.80 17.26 15.49 12.53 12.29 11.45 14.22 15.23 8.84 10.55 9.04 8.69 9.52 11.50 8.98 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Phytonadione NA 11.72 10.30 9.97 11.92 7.45 17.86 7.71 12.50 14.22 11.79 10.47 13.92 11.59 10.42 9.56 10.46 10.47 10.69 11.03 12.31 10.92 12.44 10.12 12.94 8.97 10.81 9.18 10.70 9.35 10.00 7.89 9.76 8.67 8.76 6.13 9.50 5.93 NA NA NA NA NA NA NA NA NA NA

Finished Pharmaceutical Products, Primatenemist NA 21.34 22.86 24.17 24.48 24.83 16.52 23.48 22.28 18.36 18.97 24.70 21.49 16.56 16.68 18.38 13.39 12.99 12.47 12.88 9.00 3.65 2.51 2.90 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2.19 0.18 1.56 0.40 2.36 0.83 1.18 0.13 2.28 0.72 0.77 0.93 1.22 2.55 1.13 1.12 0.68 1.96 0.29 0.23 0.44 0.06 0.98 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

9.24 4.52 4.41 1.78 0.46 1.67 0.64 1.94 1.59 1.63 1.92 2.32 1.99 1.81 5.34 2.73 4.52 2.06 3.61 3.40 5.36 4.01 3.28 3.33 4.71 3.07 2.48 5.29 1.16 2.57 1.39 0.74 3.40 1.53 0.48 0.83 2.32 0.91 1.10 3.93 5.90 5.98 0.10 NA NA NA NA NA

US 175.09 186.51 176.42 169.66 175.28 178.06 143.90 137.96 131.15 117.78 120.79 117.11 117.68 107.83 95.19 99.17 90.72 79.41 81.90 81.06 77.59 76.07 74.78 76.46 84.98 72.48 68.56 53.10 59.25 55.35 63.80 55.93 60.14 62.69 67.55 58.54 74.59 62.95 52.76 52.96 49.98 53.73 48.90 45.87 54.88 59.32 62.52 NA

Plots across concepts

IncomeStatement

Comprehensive Income Net Of Tax

Expenses

Other Nonoperating Income Expense

Balance Sheet

Goodwill

Assets

Goodwill

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Goodwill

PropertyPlantAndEquipmentNet

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Noncurrent Liabilities

Accrued Income Taxes Noncurrent

Stockholders Equity

Accumulated Other Comprehensive Income Loss Net Of Tax

CashFlow

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInOperatingActivities

Increase Decrease In Accounts Receivable

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInFinancingActivities

Net Cash Provided By Used In Financing Activities

Shares

Weighted Average Number Of Shares Outstanding Basic

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Due Year Four

FiniteLivedIntangibleAssets

Finite Lived Intangible Assets Accumulated Amortization

InventoryNet

Inventory Finished Goods

AccountsReceivable

Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept